Observe Medical Asa (OBSRV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Observe Medical Asa (OBSRV) has a cash flow conversion efficiency ratio of -0.829x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-24.83 Million ≈ $-2.61 Million USD) by net assets (Nkr29.96 Million ≈ $3.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Observe Medical Asa to measure how much of total assets are equity-financed.
Observe Medical Asa - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Observe Medical Asa's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Observe Medical Asa cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Observe Medical Asa Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Observe Medical Asa ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ASTORY Co.Ltd
KQ:241840
|
-0.064x |
|
Les Hôtels de Paris SA
PA:HDP
|
1.495x |
|
Logisys Inc
KQ:067730
|
0.025x |
|
Korea Plasma Technology U Co.Ltd
KQ:054410
|
0.004x |
|
Capital Engineering Network Public Company Limited
BK:CEN
|
0.024x |
|
Crown Lifters Limited
NSE:CROWN
|
0.022x |
|
Antilles Gold Ltd
AU:AAU
|
-0.033x |
|
Wooree E&L Co. Ltd
KQ:153490
|
0.032x |
Annual Cash Flow Conversion Efficiency for Observe Medical Asa (2016–2025)
The table below shows the annual cash flow conversion efficiency of Observe Medical Asa from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see OBSRV market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Nkr29.96 Million ≈ $3.15 Million |
Nkr-24.83 Million ≈ $-2.61 Million |
-0.829x | +34.86% |
| 2024-12-31 | Nkr24.11 Million ≈ $2.54 Million |
Nkr-30.68 Million ≈ $-3.23 Million |
-1.273x | -483.24% |
| 2023-12-31 | Nkr112.08 Million ≈ $11.79 Million |
Nkr-24.45 Million ≈ $-2.57 Million |
-0.218x | +41.25% |
| 2022-12-31 | Nkr138.31 Million ≈ $14.55 Million |
Nkr-51.37 Million ≈ $-5.41 Million |
-0.371x | -123.71% |
| 2021-12-31 | Nkr-14.12 Million ≈ $-1.49 Million |
Nkr-22.13 Million ≈ $-2.33 Million |
1.567x | +247.31% |
| 2020-12-31 | Nkr20.35 Million ≈ $2.14 Million |
Nkr-21.64 Million ≈ $-2.28 Million |
-1.064x | -10.69% |
| 2019-12-31 | Nkr14.54 Million ≈ $1.53 Million |
Nkr-13.97 Million ≈ $-1.47 Million |
-0.961x | -93.26% |
| 2018-12-31 | Nkr16.82 Million ≈ $1.77 Million |
Nkr-8.36 Million ≈ $-880.11K |
-0.497x | +42.36% |
| 2017-12-31 | Nkr11.39 Million ≈ $1.20 Million |
Nkr-9.83 Million ≈ $-1.03 Million |
-0.863x | -21.31% |
| 2016-12-31 | Nkr14.70 Million ≈ $1.55 Million |
Nkr-10.45 Million ≈ $-1.10 Million |
-0.711x | -- |
About Observe Medical Asa
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a dig… Read more